| Literature DB >> 25525873 |
Manuel Irimia1, Robert J Weatheritt2, Jonathan D Ellis3, Neelroop N Parikshak4, Thomas Gonatopoulos-Pournatzis3, Mariana Babor3, Mathieu Quesnel-Vallières3, Javier Tapial5, Bushra Raj3, Dave O'Hanlon3, Miriam Barrios-Rodiles6, Michael J E Sternberg7, Sabine P Cordes8, Frederick P Roth9, Jeffrey L Wrana8, Daniel H Geschwind4, Benjamin J Blencowe10.
Abstract
Alternative splicing (AS) generates vast transcriptomic and proteomic complexity. However, which of the myriad of detected AS events provide important biological functions is not well understood. Here, we define the largest program of functionally coordinated, neural-regulated AS described to date in mammals. Relative to all other types of AS within this program, 3-15 nucleotide "microexons" display the most striking evolutionary conservation and switch-like regulation. These microexons modulate the function of interaction domains of proteins involved in neurogenesis. Most neural microexons are regulated by the neuronal-specific splicing factor nSR100/SRRM4, through its binding to adjacent intronic enhancer motifs. Neural microexons are frequently misregulated in the brains of individuals with autism spectrum disorder, and this misregulation is associated with reduced levels of nSR100. The results thus reveal a highly conserved program of dynamic microexon regulation associated with the remodeling of protein-interaction networks during neurogenesis, the misregulation of which is linked to autism.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25525873 PMCID: PMC4390143 DOI: 10.1016/j.cell.2014.11.035
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582